These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8334938)

  • 21. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study on the complementary scheme of mass screening for colorectal cancer in an asymptomatic population].
    Zhou DY; Feng FC; Zhang YL
    Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):367-9. PubMed ID: 7867422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
    Strul H; Elyakim R; Halpern Z; Arber N
    Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice guidelines. Review of the recommendations for colorectal screening.
    Anderson J
    Geriatrics; 2000 Feb; 55(2):67-73; quiz 74. PubMed ID: 10711308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
    J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract]   [Full Text] [Related]  

  • 29. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening for colorectal cancer with fecal occult blood--an offer to the population?].
    Kronborg O
    Ugeskr Laeger; 1997 Aug; 159(33):4991-2. PubMed ID: 9281216
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of a cancer registry in a mass screening program for colorectal cancer.
    Michalek AM; Cummings KM; Gamble D
    Cancer Detect Prev; 1988; 11(3-6):353-7. PubMed ID: 3390856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of combined test of sequential fecal occult blood and albumin in the screening of colorectal neoplasms].
    Li S; Zhang C; Xu E
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):381-3. PubMed ID: 8697982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for colorectal cancer.
    Dervin JV
    J Fam Pract; 1987 Feb; 24(2):208. PubMed ID: 3806033
    [No Abstract]   [Full Text] [Related]  

  • 37. A screening primer: basic principles, criteria, and pitfalls of screening with comments on colorectal carcinoma.
    Chuong JJ
    J Clin Gastroenterol; 1983 Jun; 5(3):229-33. PubMed ID: 6345650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection--the priority in colorectal cancer.
    Messner RL; Gardner SS; Webb DD
    Cancer Nurs; 1986 Feb; 9(1):8-14. PubMed ID: 3085917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.